N-[3-(2-AMINO-4-CHLOROPHENOXY)PHENYL]-N,N-DIMETHYLAMINE
![N-[3-(2-AMINO-4-CHLOROPHENOXY)PHENYL]-N,N-DIMETHYLAMINE price.](/StructureFile/ChemBookStructure21/GIF/CB7786684.gif)
|
- $326 - $802.73
- Product name: N-[3-(2-AMINO-4-CHLOROPHENOXY)PHENYL]-N,N-DIMETHYLAMINE
- CAS: 937606-36-5
- MF: C14H15ClN2O
- MW: 262.73
- EINECS:
- MDL Number:MFCD08686787
- Synonyms:N-[3-(2-AMINO-4-CHLOROPHENOXY)PHENYL]-N,N-DIMETHYLAMINE;AKOS B034425;3-(2-Amino-4-chlorophenoxy)-N,N-dimethylaniline;Benzenamine, 3-(2-amino-4-chlorophenoxy)-N,N-dimethyl-
3 prices
Selected condition：
Brand
- AK Scientific
- American Custom Chemicals Corporation
- Crysdot
Package
- 500mg
- 5g
- ManufacturerAK Scientific
- Product number3712AF
- Product descriptionN-[3-(2-Amino-4-chlorophenoxy)phenyl]-N,N-dimethylamine
- Packaging500mg
- Price$326
- Updated2021-12-16
- Buy
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberHCH0042045
- Product descriptionN-[3-(2-AMINO-4-CHLOROPHENOXY)PHENYL]-N,N-DIMETHYLAMINE 95.00%
- Packaging500MG
- Price$802.73
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD12004698
- Product description3-(2-Amino-4-chlorophenoxy)-N,N-dimethylaniline 97%
- Packaging5g
- Price$648
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| AK Scientific | 3712AF | N-[3-(2-Amino-4-chlorophenoxy)phenyl]-N,N-dimethylamine | 500mg | $326 | 2021-12-16 | Buy |
| American Custom Chemicals Corporation | HCH0042045 | N-[3-(2-AMINO-4-CHLOROPHENOXY)PHENYL]-N,N-DIMETHYLAMINE 95.00% | 500MG | $802.73 | 2021-12-16 | Buy |
| Crysdot | CD12004698 | 3-(2-Amino-4-chlorophenoxy)-N,N-dimethylaniline 97% | 5g | $648 | 2021-12-16 | Buy |
Properties
Boiling point :389.8±37.0 °C(Predicted)
Density :1.237±0.06 g/cm3(Predicted)
pka :4.26±0.10(Predicted)
Density :1.237±0.06 g/cm3(Predicted)
pka :4.26±0.10(Predicted)
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|